Bourgeon Capital Management LLC Makes New $708,000 Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Bourgeon Capital Management LLC bought a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 1,356 shares of the medical equipment provider’s stock, valued at approximately $708,000.

Several other hedge funds also recently modified their holdings of the stock. LVW Advisors LLC boosted its holdings in Intuitive Surgical by 1.3% during the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock worth $756,000 after acquiring an additional 19 shares during the last quarter. Hazlett Burt & Watson Inc. boosted its holdings in Intuitive Surgical by 5.8% during the third quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock worth $177,000 after purchasing an additional 20 shares during the last quarter. Mitchell Mcleod Pugh & Williams Inc. grew its position in Intuitive Surgical by 4.1% in the 3rd quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock worth $247,000 after purchasing an additional 20 shares in the last quarter. Fragasso Financial Advisors Inc increased its stake in Intuitive Surgical by 3.0% in the 4th quarter. Fragasso Financial Advisors Inc now owns 687 shares of the medical equipment provider’s stock valued at $359,000 after buying an additional 20 shares during the last quarter. Finally, Ullmann Wealth Partners Group LLC lifted its position in shares of Intuitive Surgical by 1.6% during the 3rd quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock worth $653,000 after buying an additional 21 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity

In related news, CFO Jamie Samath sold 270 shares of the company’s stock in a transaction that occurred on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total value of $145,840.50. Following the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,730,093.55. This represents a 2.99 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction that occurred on Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 43,509 shares of company stock worth $22,602,212 in the last three months. Corporate insiders own 0.80% of the company’s stock.

Intuitive Surgical Trading Up 1.9 %

Shares of NASDAQ:ISRG opened at $604.12 on Wednesday. Intuitive Surgical, Inc. has a 12 month low of $362.14 and a 12 month high of $606.27. The stock has a market cap of $215.18 billion, a P/E ratio of 97.13, a P/E/G ratio of 5.04 and a beta of 1.39. The company has a 50 day moving average of $541.80 and a 200 day moving average of $500.76.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. Mizuho upped their target price on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Leerink Partners raised their target price on Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Stifel Nicolaus raised their price objective on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a report on Thursday, December 5th. Finally, Wells Fargo & Company boosted their target price on shares of Intuitive Surgical from $549.00 to $630.00 and gave the company an “overweight” rating in a research note on Wednesday, December 11th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the company. According to MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus target price of $554.17.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.